TABLE OF CONTENTS
Volume 35, Issue 12 (June (2) 2005)
Original Articles
CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors FREE
U Popat, G Carrum, R May, R Lamba, R A Krance, H E Heslop and M K Brenner
Bone Marrow Transplant 35: 1127-1132; advance online publication, April 18, 2005; doi:10.1038/sj.bmt.1704975
Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma FREE
M Arora, P B McGlave, L J Burns, J S Miller, J N Barke, T E Defor and D J Weisdorf
Bone Marrow Transplant 35: 1133-1140; advance online publication, April 18, 2005; doi:10.1038/sj.bmt.1704968
Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience FREE
H Hallböök, H Hägglund, D Stockelberg, P-G Nilsson, K Karlsson, M Björkholm, M Linderholm, A Wahlin, O Linder and B Smedmyr
Bone Marrow Transplant 35: 1141-1148; advance online publication, April 18, 2005; doi:10.1038/sj.bmt.1704974
Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study FREE
V Mishra, S Andresen, L Brinch, S Kvaløy, P Ernst, M K Lønset, J M Tangen, J Wikelund, C Flatum, E Baggerød, B Helle, S Vaaler and T P Hagen
Bone Marrow Transplant 35: 1149-1153; advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704988
The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation FREE
A R Kallianpur, L D Hall, M Yadav, D W Byrne, T Speroff, R S Dittus, J L Haines, B W Christman and M L Summar
Bone Marrow Transplant 35: 1155-1164; advance online publication, April 18, 2005; doi:10.1038/sj.bmt.1704943
Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study FREE
M H Jagasia, J P Greer, D S Morgan, S Mineishi, A A Kassim, K L Ruffner, H Chen and F G Schuening
Bone Marrow Transplant 35: 1165-1169; advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704994
Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients FREE
U G Kyle, Y Chalandon, R Miralbell, V L Karsegard, D Hans, A Trombetti, R Rizzoli, C Helg and C Pichard
Bone Marrow Transplant 35: 1171-1177; advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704996
Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation FREE
X P Ju, B Xu, Z P Xiao, J Y Li, L Chen, S Q Lu and Z X Huang
Bone Marrow Transplant 35: 1179-1186; advance online publication, April 25, 2005; doi:10.1038/sj.bmt.1704972
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors FREE
F M Foss, G M DiVenuti, K Chin, K Sprague, H Grodman, A Klein, G Chan, K Stiffler and K B Miller
Bone Marrow Transplant 35: 1187-1193; advance online publication, April 25, 2005; doi:10.1038/sj.bmt.1704984
Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning FREE
S Yoshihara, U Tateishi, T Ando, H Kunitoh, H Suyama, Y Onishi, R Tanosaki and S Mineishi
Bone Marrow Transplant 35: 1195-1200; advance online publication, April 25, 2005; doi:10.1038/sj.bmt.1704985
Mesenchymal stem cells rescue CD34+ cells from radiation-induced apoptosis and sustain hematopoietic reconstitution after coculture and cografting in lethally irradiated baboons: is autologous stem cell therapy in nuclear accident settings hype or reality? FREE
M Drouet, F Mourcin, N Grenier, C Delaunay, J F Mayol, J J Lataillade, A Peinnequin and F Hérodin
Bone Marrow Transplant 35: 1201-1209; advance online publication, April 11, 2005; doi:10.1038/sj.bmt.1704970
Correspondence
What is the impact of HLA mismatches detected by high-resolution techniques on the outcome of unrelated donor bone marrow transplantation? FREE
H D Ottinger, D W Beelen and H Grosse-Wilde
Bone Marrow Transplant 35: 1211advance online publication, April 18, 2005; doi:10.1038/sj.bmt.1704965
Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient FREE
L Chee, R L Spearing, C M Morris, M McDonald, V Hanrahan, A Ebbett, R Scott, C Florkowski, T Walmsley and W N Patton
Bone Marrow Transplant 35: 1213-1214; advance online publication, April 18, 2005; doi:10.1038/sj.bmt.1704973
Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin FREE
R Fanci, S Guidi, M Bonolis and A Bosi
Bone Marrow Transplant 35: 1215-1216; advance online publication, April 25, 2005; doi:10.1038/sj.bmt.1704976
Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation FREE
R Cordoba, R Arranz and J Cannata
Bone Marrow Transplant 35: 1217-1218; advance online publication, April 25, 2005; doi:10.1038/sj.bmt.1704977
Pneumonia caused by Trichosporon pullulans in an autologous peripheral blood stem cell transplant recipient: possible misidentification FREE
G Mele, M Musci, C Musto, L D'Amato, A Traficante and N Di Renzo
Bone Marrow Transplant 35: 1219-1220; advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704987
Hyponatremia as the presenting feature of cerebral toxoplasmosis FREE
O Duzoval
, M S Choroszy and K W Chan
Bone Marrow Transplant 35: 1221-1222; advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704989
Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia FREE
H Koharazawa, H Kanamori, M Takabayashi, S Yamaji, J Taguchi, K Fujimaki and Y Ishigatsubo
Bone Marrow Transplant 35: 1223-1224; advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704990
Allogeneic peripheral stem-cell transplantation with reduced-intensity conditioning regimen in refractory primary B-cell prolymphocytic leukemia: a long-term follow-up FREE
L Castagna, B Sarina, E Todisco, R Mazza and A Santoro
Bone Marrow Transplant 35: 1225advance online publication, May 9, 2005; doi:10.1038/sj.bmt.1704991
